181 related articles for article (PubMed ID: 34821375)
1. High Annexin A10 expression is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Yamaguchi A; Kuwai T; Sudo T; Hadano N; Tashiro H; Taniyama K; Yasuif W
Histol Histopathol; 2022 Mar; 37(3):243-250. PubMed ID: 34821375
[TBL] [Abstract][Full Text] [Related]
2. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
[TBL] [Abstract][Full Text] [Related]
3. Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma.
Yumura M; Nagano T; Jimbo N; Dokuni R; Kiriu T; Tanaka Y; Tachihara M; Itoh T; Maniwa Y; Nishimura Y; Kobayashi K
Anticancer Res; 2022 Mar; 42(3):1289-1294. PubMed ID: 35220218
[TBL] [Abstract][Full Text] [Related]
4. Annexin A10 Expression Is Associated With Poor Prognosis in Small Bowel Adenocarcinoma.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Kuwai T; Shimizu Y; Sudo T; Tashiro H; Taniyama K; Yasui W
Anticancer Res; 2021 Mar; 41(3):1349-1355. PubMed ID: 33788726
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
Wang J; Zhao S; Wang F; Wang J; Zhang Y
Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells.
Padden J; Ahrens M; Kälsch J; Bertram S; Megger DA; Bracht T; Eisenacher M; Kocabayoglu P; Meyer HE; Sipos B; Baba HA; Sitek B
Mol Cell Proteomics; 2016 Mar; 15(3):1072-82. PubMed ID: 26644413
[TBL] [Abstract][Full Text] [Related]
7. Annexin A10 is involved in the induction of pancreatic duodenal homeobox‑1 in gastric cancer tissue, cells and organoids.
Ishikawa A; Sakamoto N; Honma R; Taniyama D; Fukada K; Hattori T; Sentani K; Oue N; Yanagihara K; Tanabe K; Ohdan H; Yasui W
Oncol Rep; 2020 Feb; 43(2):581-590. PubMed ID: 31789399
[TBL] [Abstract][Full Text] [Related]
8. Novel Biomarker Panels Discriminating between Pancreatic Ductal Adenocarcinoma and Extrahepatic Bile Duct Carcinoma.
Noh BJ; Choi GM; Jang HJ; Ma CH; Oh HS; Kim M; Eom DW
Ann Clin Lab Sci; 2022 Mar; 52(2):323-331. PubMed ID: 35414511
[TBL] [Abstract][Full Text] [Related]
9. Loss of Annexin A10 Expression Is Associated with Poor Prognosis in Early Gastric Cancer.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Kuwai T; Suzuki T; Tashiro H; Taniyama K; Yasui W
Acta Histochem Cytochem; 2020 Oct; 53(5):113-119. PubMed ID: 33177783
[TBL] [Abstract][Full Text] [Related]
10. Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.
Isidro RA; Abukhiran I; Dunseth CD; Gosse MD; Humble RM; Pelletier DJ; Varshney N; Bellizzi AM; Hornick JL
Am J Surg Pathol; 2023 Apr; 47(4):440-452. PubMed ID: 36730833
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma.
Kim J; Kim MA; Jee CD; Jung EJ; Kim WH
Int J Cancer; 2009 Oct; 125(8):1842-50. PubMed ID: 19582876
[TBL] [Abstract][Full Text] [Related]
12. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
[TBL] [Abstract][Full Text] [Related]
13. Annexin A10 is a novel prognostic biomarker of papillary thyroid cancer.
Liu X; Yang M; Guo Y; Lu X
Ir J Med Sci; 2021 Feb; 190(1):59-65. PubMed ID: 32451762
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Kuwai T; Tazawa H; Suzuki T; Tashiro H; Taniyama K; Yasui W
Anticancer Res; 2022 Apr; 42(4):1707-1717. PubMed ID: 35346989
[TBL] [Abstract][Full Text] [Related]
15. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
Shimizu T; Kasamatsu A; Yamamoto A; Koike K; Ishige S; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
[TBL] [Abstract][Full Text] [Related]
16. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.
Kim JK; Kim PJ; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Shan JM; Ping WY; Park WS; Lee JY; Nam SW
Oncol Rep; 2010 Sep; 24(3):607-12. PubMed ID: 20664964
[TBL] [Abstract][Full Text] [Related]
18. Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system.
Lu SH; Yuan RH; Chen YL; Hsu HC; Jeng YM
Histopathology; 2013 Nov; 63(5):640-8. PubMed ID: 24024557
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma.
Li HB; Wang JL; Jin XD; Zhao L; Ye HL; Kuang YB; Ma Y; Jiang XY; Yu ZY
BMC Cancer; 2021 Sep; 21(1):1039. PubMed ID: 34530774
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]